US Stock MarketDetailed Quotes
TELO Telomir Pharmaceuticals
- 5.020
- -0.560-10.04%
Close Jun 20 16:00 ET
- 5.270
- +0.250+4.98%
Post 19:39 ET
148.64MMarket Cap-7893P/E (TTM)
5.500High5.020Low26.02KVolume5.430Open5.580Pre Close135.65KTurnover2.60%Turnover RatioLossP/E (Static)29.61MShares20.72052wk High49.22P/B5.02MFloat Cap4.76052wk Low--Dividend TTM1.00MShs Float20.720Historical High--Div YieldTTM8.60%Amplitude4.760Historical Low5.212Avg Price1Lot Size
Telomir Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -163.60%-1.94M | -723.58%-3.86M | -325.04%-1.09M | -2,331.29%-2M | -33.58K | -735.74K | -292.53%-468.66K | -255.79K | -82.4K | -119.4K |
| Net income from continuing operations | -1,195.12%-6.25M | -1,430.40%-13.07M | -1,814.86%-9.33M | -632.91%-1.71M | ---1.55M | ---482.94K | -518.36%-854.15K | ---487.1K | ---233.5K | ---138.13K |
| Operating gains losses | ---- | --7.49M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non cash items | --4.34M | --1.61M | --730.23K | --757.17K | ---- | ---- | ---- | ---- | ---- | ---- |
| Change In working capital | 90.76%-23.35K | -70.47%113.84K | -90.06%23K | -794.31%-1.05M | --1.39M | ---252.8K | 1,957.57%385.49K | --231.31K | --151.1K | --18.74K |
| -Change in prepaid assets | ---98.1K | ---713 | --250 | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| -Change in payables and accrued expense | 129.57%74.74K | -70.28%114.56K | -90.16%22.75K | -793.67%-1.05M | --1.39M | ---252.8K | 1,957.57%385.49K | --231.31K | --151.1K | --18.74K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -163.60%-1.94M | -723.58%-3.86M | -325.04%-1.09M | -2,331.29%-2M | ---33.58K | ---735.74K | -292.53%-468.66K | ---255.79K | ---82.4K | ---119.4K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 608.10%5.21M | 721.05%3.86M | 332.87%1.09M | 2,388.86%1.99M | 46.4K | 736.13K | 293.72%470.08K | 250.88K | 80K | 119.4K |
| Net issuance payments of debt | ---101K | 573.80%3.12M | 338.50%1.07M | 2,578.18%2.14M | ---93.35K | --0 | --462.39K | --243.19K | --80K | ---- |
| Net common stock issuance | 483.30%5.83M | --1M | --90K | --0 | ---90K | --1M | --0 | --0 | --0 | ---- |
| Net other financing activities | -96.87%-519.48K | -3,429.04%-255.97K | ---70.39K | ---151.46K | --229.75K | ---263.87K | -93.56%7.69K | ---- | ---- | --119.4K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 608.10%5.21M | 721.05%3.86M | 332.87%1.09M | 2,388.86%1.99M | --46.4K | --736.13K | 293.72%470.08K | --250.88K | --80K | --119.4K |
| Net cash flow | ||||||||||
| Beginning cash position | -13.25%1.23K | --1.42K | -61.26%2.45K | 67.67%14.63K | --1.81K | --1.42K | --0 | --6.33K | --8.73K | --0 |
| Current changes in cash | 843,478.09%3.27M | -113.25%-188 | 75.14%-1.22K | -408.43%-12.18K | --12.82K | --388 | --1.42K | ---4.91K | ---2.4K | ---- |
| End cash Position | 181,101.66%3.27M | -13.25%1.23K | -13.25%1.23K | -61.26%2.45K | --14.63K | --1.81K | --1.42K | --1.42K | --6.33K | --0 |
| Free cash flow | -163.60%-1.94M | -723.58%-3.86M | -325.04%-1.09M | -2,331.29%-2M | ---33.58K | ---735.74K | -292.53%-468.66K | ---255.79K | ---82.4K | ---119.4K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
